Bionano Genomics Inc. Is set at 080 with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 22823.
Breaking Stock News Nano Dimension Merger Bionano Genomics Bngo Stock Analysis Nndm Stock News Youtube
Get the hottest stocks to trade every.
Bionano genomics news. Hier finden Sie die News-Seite für den Wert Bionano Genomics. BNGO stock went up in the previous closing by 209 with a 538 per share price. Weighing The Future Prospects Against The Here And Now.
Bionano Genomics Inc. BNGO announced today that the two large laboratories of the United Kingdom have adopted its Saphyr System for optical genome mapping after which the BNGO stock price saw a push of 372 to reach 558 a share at the time of this writing. BNGO closed the most recent trading day at 697 moving -113 from the previous trading session.
Life science company Bionano Genomics BNGO has been getting a lot of attention on Wall Street on both the long and short side. Bionano Genomics BNGO is a life science instrumentation businessTo be more specific BNGO operates in the area of genome analysis. Bionano Genomics Inc.
Analysts have predicted the quarterly earnings per share to grow by -004 per share this quarter however they have predicted. Juniper Point Amy Conrad T. Bionano Genomics Inc.
Yet analysts are ramping up their growth forecast for the fiscal year 2021. Bionano Genomics Inc whose market valuation is 205 Billion at the time of this writing is expected to release its quarterly earnings report Jun 21 2021- Jun 25 2021. In the rating firms projections.
March 1 2019. BNGOs products include integrated primarysecondary software automated imaging instruments nanochannel chips and reagents that are application-specific. The companys stock price has collected 883 of gains in the last five trading sessions.
The new note on the price target was released on April 08 2020 representing the official price target for Bionano Genomics Inc. Bionano Genomics 9540 Towne Centre Drive Suite 100 San Diego CA 92121. It is anticipated.
As the original Saphyr platform is ramping up BioNano has already announced that the next-generation version will have a prototype ready by the end of 2021. Data delayed 15 minutes unless otherwise indicated view delay times for all exchanges. Revenue is predicted to grow 867 this quarter and then jump 444 in the quarter after that.
This move lagged the SP 500s daily loss of 009. The company report on April 22 2021 that Bionano Genomics Announces Publication of New Approach to Study DNA Replication Using Optical Genome Mapping With Saphyr Potentially Supporting Development of Cancer Drugs Targeting Replication Pathways. Die mittlere jährliche Rendite für Wertpapiere aus der gleichen Branche Life Sciences Werkzeuge und Dienstleistungen beträgt 1621 Prozent.
Es grünt Lesen Sie die neusten Einträge im Bionano Genomics-Forum und diskutieren Sie mit unserer Börsennews-Commun. Bionano Genomics Inc. 16 Zeilen News zur BIONANO GENOMICS AKTIE und aktueller Realtime-Aktienkurs Bionano Genomics.
NASDAQBNGO went up by 336 from its latest closing price compared to the recent 1-year high of 1569. Investors optimism about the companys current quarter earnings report is understandable. Bionano Genomics BNGO new study is likely to lead to a new level of cancer research and drug discovery with reduced side effects demonstrating the importance of optical genome.
Bionano Genomics DickimMinus schreibt. Bionano Genomics Saphyr System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot. The Average True Range ATR for Bionano Genomics Inc.
Bionano Genomics News. The Price to Book ratio for the last. Unfassbar jetzt winkt der nächste Schrittliegt Bionano Genomics damit 96897 Prozent über dem Durchschnitt 1551 Prozent.
018 40166. Auf dieser Seite finden Sie alle Bionano Genomics News und Nachrichten zur Bionano Genomics Aktie. BIONANO GENOMICS A2JRLZ US09075F1075 mit aktuellem Aktienkurs Charts News und Analysen.
DAX-004 152898 TecDAX-003 35345 MDAX-015 329886 ESTX50. Press Release reported on. Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics.
BNGO shares have gone up 118031 during the last six months with a year-to-date growth rate less than the industry average at -5128 against 82. RT Real-Time RTB Real. Bionano Genomics revealed the publication of a new Saphyr-based method which is designed for studying DNA replication in human genomes.
BNGO price surged by 336 percent to reach at 02. Get News and Updates Via Email Alerts. By rimotevst May 27 2019 0 comments.
